A detailed history of Nordea Investment Management Ab transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 4,370,373 shares of DNA stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,370,373
Previous 4,412,457 0.95%
Holding current value
$1.44 Million
Previous $7.46 Million 32.02%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$1.06 - $1.67 $44,609 - $70,280
-42,084 Reduced 0.95%
4,370,373 $5.07 Million
Q4 2023

Jan 10, 2024

BUY
$1.26 - $1.79 $272,706 - $387,416
216,434 Added 5.16%
4,412,457 $7.46 Million
Q3 2023

Nov 13, 2023

BUY
$1.61 - $2.54 $1.17 Million - $1.85 Million
727,417 Added 20.97%
4,196,023 $7.59 Million
Q2 2023

Jul 07, 2023

BUY
$1.14 - $1.95 $3.95 Million - $6.76 Million
3,468,606 New
3,468,606 $6.45 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $425M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.